Search

everythinglearnresearchcommunity

for

Search:↓

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Targeting colon cancer stem cells might lead to better treatment results.

Nanoparticles can effectively treat diseases by modifying blood vessel growth.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Exosome therapy shows promise for treating hair loss but needs more research and standardization.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Nanozymes show promise for effective and safe cancer treatment.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Exosome therapy could help with hair loss, but more research and regulation are needed.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Suppressing eIF4E can prevent hair loss from chemotherapy.

MicroRNAs could improve skin tissue engineering by regulating cells and changing the skin's bioactive environment.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Machine learning and single-cell analysis improve understanding and treatment of wound healing.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

The document discusses various skin disorders and new therapeutic approaches.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

Exosomes show promise for treating skin diseases and improving skin regeneration.